ReviewCurrent neurology and neuroscience reports2009
The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke.
Review in Current neurology and neuroscience reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 49 citations in OpenAlex.
- Associations of long-term exposure to source-specific PMEuropean archives of psychiatry and clinical neuroscience · 2026Article
- Stroke from Infection.Cerebrovascular diseases extra · 2025Review
- Assessing the Impact of Frailty on Infection Risk in Older Adults: Prospective Observational Cohort Study.JMIR public health and surveillance · 2024Observational
- Optical Coherence Tomography Angiography Assessment of the Optic Nerve Head in Patients Hospitalized Due to COVID-19 Bilateral Pneumonia.Medicina (Kaunas, Lithuania) · 2024Article
- Adult immunization practices, challenges and opportunities in Central America and the Caribbean: Advisory board proceedings.Human vaccines & immunotherapeutics · 2022Article
- SARS-CoV-2 mediated neurological disorders in COVID-19: Measuring the pathophysiology and immune response.Life sciences · 2022Review
- Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke.Biomedicines · 2022Review
- Neurological complications and infection mechanism of SARS-COV-2.Signal transduction and targeted therapy · 2021Review
- Neurological Manifestations and Outcomes in a Retrospective Cohort of Mexican Inpatients with SARS-CoV-2 Pneumonia: Design of a Risk Profile.Healthcare (Basel, Switzerland) · 2021Article
- Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.International journal of environmental research and public health · 2021Review
- Severe Neurologic Complications of SARS-CoV-2.Current treatment options in neurology · 2021Review
- Cognitive Impairment After COVID-19-A Review on Objective Test Data.Frontiers in neurology · 2021Review
- The nervous system-A new territory being explored of SARS-CoV-2.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020Review
- The Frequency of Neurological Symptoms in COVID-19 Patients at a Tertiary Care Hospital in Pakistan.Cureus · 2020Article
- Article
- Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.JAMA neurology · 2020Review
- SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.International journal of molecular sciences · 2020Review
- Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.PLoS neglected tropical diseases · 2020Article
- COVID-19 and stroke in sub-Saharan Africa: case series from Dar es Salaam.The Pan African medical journal · 2020Article
- Cross-Reactivity as a Mechanism Linking Infections to Stroke.Frontiers in neurology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is well established that several infectious diseases can directly lead to ischemic or hemorrhagic stroke during their course. It appears possible that common viral and bacterial infections can increase the susceptibility to stroke by promoting atherosclerosis, inflammation, and local thrombosis. Stroke commonly leads to disruption of protective mechanisms against infection and induces a cascade of anti-inflammatory and immunosuppressive reactions, which greatly increases the risk of infection. The social and economic costs of post-stroke infections and their impact on stroke morbidity and outcome are dramatic. Understanding the pathophysiologic links between stroke and infection is therefore of paramount importance, and effective preventive strategies to reduce the risk of infection are needed. This article summarizes current clinical and experimental data regarding the interactions between stroke and infection and outlines possible targets for therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.